End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,000 KRW | -3.64% | -12.45% | +105.25% |
Business Summary
Number of employees: 91
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cold Chain
80.9
%
| 14,007 | 29.1 % | 43,500 | 80.9 % | +210.55% |
Electronic
16.9
%
| 9,982 | 20.7 % | 9,090 | 16.9 % | -8.93% |
Medical Device
2.2
%
| 24,143 | 50.2 % | 1,159 | 2.2 % | -95.20% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
97.0
%
| 46,825 | 97.3 % | 52,134 | 97.0 % | +11.34% |
Japan
3.0
%
| 1,308 | 2.7 % | 1,615 | 3.0 % | +23.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ki-Hong An
CEO | Chief Executive Officer | 57 | - |
Yeok-Dong Kim
AUD | Comptroller/Controller/Auditor | 64 | 21-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yang-Gon Jin
BRD | Director/Board Member | 58 | - |
Jong-Won Kim
BRD | Director/Board Member | 61 | - |
Chang-Yoon Lim
BRD | Director/Board Member | 58 | - |
Jung-Hwan Moon
BRD | Director/Board Member | 61 | - |
Ki-Hong An
CEO | Chief Executive Officer | 57 | - |
Han-Seung Koo
BRD | Director/Board Member | 59 | - |
Jae-Hoon Kim
BRD | Director/Board Member | 59 | 21-10-31 |
Jeong-Sang Lee
BRD | Director/Board Member | 49 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 79,240,638 | 68,423,751 ( 86.35 %) | 323,020 ( 0.4076 %) | 86.35 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HLB INNOVATION CO.,LTD. 2.87% | 2,074,688 | 2.87% | 6,920,122 $ |
640,951 | 0.81% | 5,207,932 $ | |
HLB BIOSTEP CO.,LTD. 1.86% | 1,606,500 | 1.86% | 4,335,606 $ |
Company contact information
HLB Therapeutics Co., Ltd.
#2201, Parkview Tower 248 Jeongjail-ro
13554, Seongnam-si
+
http://www.gtreebnt.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+105.25% | 538M | |
+20.81% | 72.78B | |
-1.76% | 24.24B | |
+8.80% | 8.59B | |
+9.15% | 8.38B | |
-19.42% | 8.09B | |
+7.33% | 4.81B | |
+17.69% | 4.32B | |
-3.66% | 4.05B | |
-2.75% | 3.93B |
- Stock Market
- Equities
- A115450 Stock
- Company HLB Therapeutics Co.,Ltd.